MedPath

AG-LEVOCARB

AG-LEVOCARB

Approved
DIN Number

02551373

Drug Class

Human

Market Date

N/A

Company
HC

angita pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02551373
AIG Number0210315001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

CARBIDOPAActive
Strength: 25 MG
Monograph: CARBIDOPA
LEVODOPAActive
Strength: 250 MG
Monograph: LEVODOPA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.